QC
GUTS icon

Quadrature Capital’s Fractyl Health GUTS Stock Holding History

Quadrature Capital’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-290,714
Closed -$640K – 1937
2025
Q4 		$640K Buy
290,714
+277,174
+2,047% +$446K 0.01% 630
2025
Q3 		$21.4K Buy
+13,540
New +$17.6K ﹤0.01% 987

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quadrature Capital's GUTS Position: Q1 2026 in Review

Quadrature Capital sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 290,714 shares — an estimated $640K sold.

Quadrature Capital first reported a position in GUTS in Q3 2025 and held it in 2 quarters. The position peaked at $640K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Quadrature Capital reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 290,714 Fractyl Health shares in Q1 2026, an estimated $640K.
  • Quadrature Capital first reported a position in Fractyl Health in Q3 2025 and held it in 2 quarters.
  • Quadrature Capital's Fractyl Health position peaked at $640K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.